Skip to main content
2023 IKCS: North America Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.

  1. Home

  • Friday, Nov 10th
    3:05 PM – 3:15 PM CST
    4: LITESPARK-013: Randomized Phase 2 Study of Two Doses of Belzutifan in Patients With Advanced Clear Cell Renal Cell Carcinoma (ccRCC)
    Location: Legends ABCD
    Lead Author: Pooja Ghatalia, MD – Fox Chase Cancer Center
    Therapeutics (Local- Primary and Metastasis)